Profile
Takeda Ventures is a venture capital firm based in Japan. It is the corporate venture arm of Takeda Pharmaceutical Company, established to build strategic partnerships and investments in biotechnology and life sciences. The firm operates with a team of experienced investors and scientists who focus on identifying and nurturing innovative healthcare solutions. Its team structure and emphasis on integrating science with investment set it apart in the industry.
Takeda Ventures invests in a diverse range of biotechnology and life sciences sectors, including pharmaceuticals, MedTech, and healthtech, with a primary interest in early-stage companies. The firm looks to partner with companies that align with Takeda's strategic priorities in therapeutic areas such as oncology and immunology. While specific financial figures such as total assets under management are not disclosed, the firm aims to provide strategic support and capital to its portfolio companies through strategic alignment and shared goals.
Notable investments by Takeda Ventures include companies like Denali Therapeutics - focusing on neurodegenerative diseases, and Wave Life Sciences - working on oligonucleotide therapies. The firm has strategically co-invested with like-minded partners and maintained a global outreach to innovative companies around the globe, reinforcing its commitment to advancing healthcare through innovation and collaboration.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.